A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease.
U-M Study Finds New Class of Cancer Drugs Could Work in Colon Cancers With Genetic Mutation
A new study from the University of Michigan Comprehensive Cancer Center finds that a class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations
A new study from the University of Michigan Comprehensive Cancer Center finds that a class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations
While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.
New Cancer Drug Shrinks Tumors With Few Side Effects
Scientists at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.
Scientists at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.
All-New 'Nanobody' Agents Could Help Docs Identify Beneficial Breast Cancer Drugs for Patients
A study has suggested that new Nanobody agents can help physicians identify patients most likely to benefit from breast cancer drug therapies.
A study has suggested that new Nanobody agents can help physicians identify patients most likely to benefit from breast cancer drug therapies.
